Cancer imposes catastrophic health expenditure in India, with medicines constituting over 60% of out-of-pocket expenditure. Research shows wide price variations, limited cost containment.
Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly diagnosed advanced or metastatic non-small cell lung cancer.
Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs.
Sitharaman in the 2026-27 Budget has shifted focus away from Amaravati and Polavaram. But TDP is confident about leveraging allocations to accelerate Andhra’s 'next phase of growth'.
After lapses exposed by terror attacks at Pahalgam and Delhi's Red Fort, Centre has hiked Intelligence Bureau's expenditure for investments in long-term assets from Rs 257 cr to Rs 2,549 cr.
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.
COMMENTS